About OCULAR THERAPEUTIX, INC
Ocular Therapeutix is a biopharmaceutical company focused on developing innovative treatments for retinal diseases, with its investigational therapy AXPAXLI™ (OTX-TKI) currently in Phase 3 clinical trials for wet AMD.
Development of investigational therapies for retinal diseasesClinical trial design and execution for retinal disease treatmentsIntravitreal injection administration of hydrogel-based therapies
Is this your company?
Claim OCULAR THERAPEUTIX, INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim OCULAR THERAPEUTIX, INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.